These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
129 related items for PubMed ID: 78793
1. [Indications and risks of anti-arrhythmia treatment with propafenone (author's transl)]. Beck OA, Hochrein H. Dtsch Med Wochenschr; 1978 Aug 11; 103(32):1261-5. PubMed ID: 78793 [Abstract] [Full Text] [Related]
2. [Propafenon, a new antiarrhythmic agent for the treatment of ectopic and rapid cardiac arrhythmias (author's transl)]. Beck OA. Med Klin; 1975 Jan 17; 70(3-2):95-101. PubMed ID: 48183 [Abstract] [Full Text] [Related]
3. [Clinical experience with propafenone in paroxysmal supraventricular reciprocating tachycardias]. Furlanello F, Vergara G, Dal Forno P, Disertori M, Inama G. G Ital Cardiol; 1984 May 17; 14(5):379-80. PubMed ID: 6468821 [Abstract] [Full Text] [Related]
4. [The treatment of arrhythmias in infants and children using propafenone]. Dressler F, Grävinghoff L, Grütte E, Jüngst BK, Liersch R, Nomayo H, Puls I, Rautenburg HW, Schmaltz A, Schumacher G. Monatsschr Kinderheilkd; 1985 Mar 17; 133(3):154-7. PubMed ID: 4010670 [Abstract] [Full Text] [Related]
5. [Arrhythmias in the Wolff-Parkinson-White syndrome (author's transl)]. Lüderitz B, Steinbeck G. MMW Munch Med Wochenschr; 1976 Mar 19; 118(12):377-82. PubMed ID: 817167 [Abstract] [Full Text] [Related]
6. [Propafenon therapy of arrhythmias in infancy and childhood (author's transl)]. Weber H, Eigster G, Wesselhoeft H. Monatsschr Kinderheilkd; 1981 Jul 19; 129(7):410-3. PubMed ID: 6167855 [Abstract] [Full Text] [Related]
7. [Anti-arrhythmic effect of oral propafenone. Apropos of 70 cases]. Coumel P, Leclercq JF, Assayag P, Maisonblanche P, Cauchemez B. Arch Mal Coeur Vaiss; 1984 Nov 19; 77(12):1370-82. PubMed ID: 6439161 [Abstract] [Full Text] [Related]
8. [Therapy of ventricular arrhythmias with propafenone]. Petri H, Kafka W, Rudolph W. Herz; 1985 Feb 19; 10(1):44-52. PubMed ID: 2579879 [Abstract] [Full Text] [Related]
9. Usefulness of programmed stimulation in predicting efficacy of propafenone in long-term antiarrhythmic therapy for paroxysmal supraventricular tachycardia. Manz M, Steinbeck G, Lüderitz B. Am J Cardiol; 1985 Oct 01; 56(10):593-7. PubMed ID: 4050693 [Abstract] [Full Text] [Related]
12. [Verapamil in the study and treatment of supraventricular tachycardias, with special reference to pre-excitation]. Krikler DM. Minerva Med; 1975 May 26; 66(39):1914-22. PubMed ID: 236526 [Abstract] [Full Text] [Related]
13. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study]. Lardoux H, Maison Blanche P, Marchand X, Canler A, Rouesnel P, Bleinc D, Péraudeau P, Scheck F. Ann Cardiol Angeiol (Paris); 1996 Oct 26; 45(8):469-79. PubMed ID: 8952741 [Abstract] [Full Text] [Related]
14. [Treatment of cardiac arrhythmias in aged patients (author's transl)]. Hochrein H. Aktuelle Gerontol; 1980 Jan 26; 10(1):11-6. PubMed ID: 6158269 [Abstract] [Full Text] [Related]
16. European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias. Coumel P, Leclercq JF, Assayag P. Am J Cardiol; 1984 Nov 14; 54(9):60D-66D. PubMed ID: 6208770 [Abstract] [Full Text] [Related]